Striatonigral Degeneration Questions & Answers

Updated: Nov 13, 2019
  • Author: Ahmad El Kouzi, MD; Chief Editor: Selim R Benbadis, MD  more...
  • Print
Questions & Answers

Overview

What is multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is the pathophysiology of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is the prevalence of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is the prognosis of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What are the possible complications of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is included in the patient education about multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Presentation

What are the signs and symptoms of parkinsonism in multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What are the dysautonomic signs and symptoms of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What are the sleep-related signs and symptoms of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which clinical history findings are characteristic of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which clinical history findings suggest an alternative diagnosis to multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which parkinsonism findings are characteristic of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which dysautonomic findings are characteristic of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which cerebellar findings are characteristic of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which cognitive findings are characteristic of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which physical findings are characteristic of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which physical findings suggest alternative diagnoses to multiple system atrophy with predominantly parkinsonian features (MSA-P)?

DDX

What are the differential diagnoses for Striatonigral Degeneration?

Workup

What is the role of lab tests in the diagnosis of multiple system atrophy with predominantly parkinsonian features (MSA-P)

What is the role of electromyography in the workup of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is the role of clonidine growth hormone test in the workup of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is the role of a neuropsychiatric evaluation in the workup of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is the role of sleep studies in the workup of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which histologic findings are characteristic of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is the role of autonomic tests in the workup of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is the role of skin biopsy in the workup of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is the role of imaging in the workup of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Treatment

How is multiple system atrophy with predominantly parkinsonian features (MSA-P) treated?

When is inpatient care required for multiple system atrophy with predominantly parkinsonian features (MSA-P)?

What is included in the long-term monitoring of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which specialist consultations are beneficial to patients with multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which dietary modifications are used in the treatment of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which activity modifications are used in the treatment of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Medications

What is the role of medications in the treatment of multiple system atrophy with predominantly parkinsonian features (MSA-P)?

Which medications in the drug class Benzodiazepines are used in the treatment of Striatonigral Degeneration?

Which medications in the drug class Alpha1 Agonists are used in the treatment of Striatonigral Degeneration?

Which medications in the drug class Corticosteroids are used in the treatment of Striatonigral Degeneration?

Which medications in the drug class Antiparkinson Agents, Dopamine Agonists are used in the treatment of Striatonigral Degeneration?